Member Info for Jarv55

Highlights

· Company in advanced discussions with a new strategic investor regarding a potential substantial investment in the Company and licence to develop the Group's products in Asia

· Company awaiting feedback from the FDA on the regulatory path for the Company's lead product, MTD201, following positive first-in-human Phase I proof of concept exploratory study data received in Q3 2018

· Scheduled Phase I dose escalation component of MTX110 clinical trial in children with DIPG completed. FDA approval received to administer higher doses due to good tolerability

· Continued restructuring of the Group's operation to focus on clinical programs, and further streamline future costs

· Potential for non-dilutive funding (in the form of loans and grants) to support a significant proportion of expected scale-up costs for the manufacture of MTD201

· Transition to R&D focused strategy complete, and recent favourable data generated on lead program

Can't be long until the $8million funding comes in

Commenting on the announcement, Dr Craig Cook, Chief Executive Office of Midatech Pharma, said: "This ongoing regional government support enables us to continue and potentially accelerate the progress of MTD201 development towards submission for approval, as well as further develop our Q-Sphera platform. We believe this sustained release technology has the potential to drastically improve the manufacturing process and clinical characteristics of existing drugs, providing more effective, convenient, precise and comfortable treatments for patients. We look forward to continuing the scale up program in Bilbao, as we work on driving MTD201 towards the market and establishing Q-Sphera as a leading platform in the multibillion dollar market for sustained release treatments."

Gap to fill at 11p

Think this is going to have a strong push up this afternoon

What news is due here?

Take a look at who he used to work for
https://register.fca.org.uk/ShPo_individualdetailsPage?id=003b000000LVm2NAAT

Please vote people https://twitter.com/Jarvy55/status/1083303456528613382

Yep bring on the flow rates

for shareholders it eliminates the risks of the business and allows the funds to redeployed in businesses with stronger growth prospects.

Nice bounce back loads of stops must of been hit

Not selling any that would be stupid hopefully this gm will come quickly get it out of the way. Think Lenigas should go on the board at least he knows how to promote.

You would think after Tidswells dodgy loan he would be keeping under the radar very odd indeed.

Well it closed the gap down now to wait for the gap fill up https://invst.ly/9qt-0

Lets see who buys the cheapies

Vonks strikes again idiot why didn't he offer to shareholders?

Chart does look good lots of targets to go for. https://invst.ly/9qpfw

Nice too see this finally moving in the right direction if it clears the 100ma on the chart it should head towards the first gap at approx 15.51

Angus certainly need some coaching in promotion. Like you say Alan twitter is free.

Nice one Pboo